Par Drugs And Chemicals Limited Total Assets
Par Drugs And Chemicals Limited total assets. Based on the latest financial reports, Par Drugs And Chemicals Limited (PAR) holds total assets worth Rs1.29 Billion INR (≈ $13.97 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see PAR market cap for the company's overall valuation and market capitalisation.
Total Assets of Par Drugs And Chemicals Limited (2016–2026)
Total assets of Par Drugs And Chemicals Limited from 2016 to 2026. This chart illustrates how Par Drugs And Chemicals Limited's total assets have evolved over time, based on quarterly financial data. See PAR stock price and chart for real-time trading data and today's change.
Par Drugs And Chemicals Limited - Asset Composition Analysis
Par Drugs And Chemicals Limited Total Assets Breakdown (March 2026)
Par Drugs And Chemicals Limited total assets breakdown as of March 2026. Par Drugs And Chemicals Limited's total assets of Rs1.29 Billion consist of 49.8% current assets and 50.2% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 32.4% |
| Accounts Receivable | Rs121.39 Million | 9.4% |
| Inventory | Rs53.73 Million | 4.2% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs0.00 | 0.0% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2016–2026)
This chart illustrates how Par Drugs And Chemicals Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is Par Drugs And Chemicals Limited's working capital to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Par Drugs And Chemicals Limited's current assets represent 49.8% of total assets in 2026, an increase from 25.2% in 2016.
- Cash Position: Cash and equivalents constituted 32.4% of total assets in 2026, up from 1.6% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 9.4% of total assets.
Par Drugs And Chemicals Limited Competitors by Total Assets
Key competitors of Par Drugs And Chemicals Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262
|
China | CN¥9.54 Billion |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211
|
China | CN¥6.44 Billion |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
|
China | CN¥1.54 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Bide Pharmatech Co. Ltd. A
SHG:688073
|
China | CN¥2.54 Billion |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976
|
China | CN¥4.69 Billion |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365
|
China | CN¥2.26 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥25.73 Billion |
Par Drugs And Chemicals Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.68 | 3.31 | 2.58 |
| Quick Ratio | 4.29 | 2.94 | 2.39 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rs505.82 Million | Rs382.93 Million | Rs252.06 Million |
Par Drugs And Chemicals Limited - Advanced Valuation Insights
This section examines the relationship between Par Drugs And Chemicals Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.96 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 8.2% |
| Total Assets | Rs1.29 Billion |
| Market Capitalization | $15.06 Million USD |
Valuation Analysis
Below Book Valuation: The market values Par Drugs And Chemicals Limited's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Par Drugs And Chemicals Limited's assets grew by 8.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Par Drugs And Chemicals Limited (2016–2026)
The table below shows the annual total assets of Par Drugs And Chemicals Limited from 2016 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | Rs1.29 Billion ≈ $13.97 Million |
+8.23% |
| 2025-03-31 | Rs1.19 Billion ≈ $12.91 Million |
+17.50% |
| 2024-03-31 | Rs1.02 Billion ≈ $10.99 Million |
+14.34% |
| 2023-03-31 | Rs888.68 Million ≈ $9.61 Million |
+12.93% |
| 2022-03-31 | Rs786.90 Million ≈ $8.51 Million |
+3.02% |
| 2021-03-31 | Rs763.84 Million ≈ $8.26 Million |
+27.06% |
| 2020-03-31 | Rs601.15 Million ≈ $6.50 Million |
+17.06% |
| 2019-03-31 | Rs513.55 Million ≈ $5.55 Million |
-4.79% |
| 2018-03-31 | Rs539.39 Million ≈ $5.83 Million |
-3.75% |
| 2017-03-31 | Rs560.41 Million ≈ $6.06 Million |
-3.43% |
| 2016-03-31 | Rs580.31 Million ≈ $6.28 Million |
-- |
About Par Drugs And Chemicals Limited
Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, m… Read more